Archives of Internal Medicine · 1973 · 67 citations · 14 references
MedicineCardiologyPharmacologyClinical PharmacologyExperimental PharmacologyPharmacodynamicsCardiac PharmacotherapyCardiovascular Drug SafetyCardiovascular PharmacodynamicsCardiovascular PharmacologyGlucagon TherapyHemodynamic PharmacologyBeta-blocker ToxicityCardiovascular Drug PharmacologyCardiovascular Drug ToxicityGlucagon TreatmentHeart RateHemodynamic Drug EffectsMyocardial Contractility ModulationPropranolol Therapy
The hemodynamic properties of glucagon hydrochloride and isoproterenol hydrochloride were compared in anesthetized mongrel dogs before and after complete β-adrenergic blockade with propranolol hydrochloride. Before propranolol blockade, glucagon and isoproterenol enhanced myocardial performance, although the action of glucagon persisted longer than that of isoproterenol. Following propranolol blockade, glucagon enhanced myocardial contractility and heart rate to a greater extent than isoproterenol. Glucagon is clinically superior in reversing the toxic effects of propranolol.
14
Gerald Glick, William W. Parmley, Andrew S. Wechsler et al. · Circulation Research · 1968 · 248 citations · Full text